| Name | Title | Contact Details |
|---|---|---|
Dhiraj Sankala |
Chief Technology Officer | Profile |
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Coriell Institute for Medical Research is a Camden, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avalere Health, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Washington, DC. To find more information about Avalere Health, LLC, please visit www.avalerehealth.net
VirtuOx is the worlds largest provider of Respiratory, Sleep and Insomnia Testing in the privacy and comfort of your home!
EarlySense is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. EarlySense is based in Waltham, MA. You can find more information on EarlySense at www.earlysense.com